Lichen Sclerosus — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Ultrapotent topical corticosteroid (Clobetasol propionate 0.05%)
Ultrapotent topical corticosteroids (Clobetasol propionate 0.05%) are first-line treatment for vulval lichen sclerosus per BAD guidelines. The standard regimen is once daily for 4 weeks, then alternate days for 4 weeks, then twice weekly for 4 weeks, then as needed for maintenance. Topical calcineurin inhibitors are second-line. Long-term follow-up is essential due to the 4-5% risk of vulval SCC developing in affected skin. Moderate potency steroids are insufficient for genital lichen sclerosus.
Reference: BAD 2018 Guidelines for management of lichen sclerosus